Synlett 2002(10): 1724-1726
DOI: 10.1055/s-2002-34214
LETTER
© Georg Thieme Verlag Stuttgart · New York

Enantioselective Synthesis of 6-nor-Fluvirucinin B1

Anne W. Baltruscha, Franz Bracher*b
a Institut für Pharmazeutische Chemie, Technische Universität Braunschweig, Beethovenstr. 55, 38106 Braunschweig, Germany
b Department für Pharmazie-Zentrum für Pharmaforschung, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13,81377 München, Germany
Fax: +49(89)21807802; e-Mail: Franz.Bracher@cup.uni-muenchen.de;
Further Information

Publication History

Received 8 August 2002
Publication Date:
23 September 2002 (online)

Abstract

An enantioselective synthesis of the 6-nor-derivative 3 of the antiviral macrocyclic lactam fluvirucinin B1 (2) is presented. Key steps are two regioselective ring opening reactions of chiral epoxides, and a ring-closing metathesis with Grubbs’ catalyst. The choice of appropriate protective groups was essential for the success and efficiency of the synthesis.

11

The corresponding trityl ether was also examined, but gave ring opening products only in yields <10%. Similar observations with bulky protective groups have already been described. [13]

18

Ring-closing metathesis: A solution of diene 18 (30 mg, 0.075 mmol) and Ti(i-PrO)4 (6 mg, 0.02 mmol) in 50 mL anhydrous CH2Cl2 was refluxed under N2 for 1 hour. Then 2 mg (0.002 mmol) benzylidene-bis(tricyclohexylphos-phine)dichlororuthenium, dissolved in 0.5 mL CH2Cl2, was added and the mixture was refluxed for 4 days. Purification by flash column chromatography (silica, hexanes-ethyl acetate 5:2) gave 20 mg (72%) 19 as colorless crystals, mp 176 °C. [α]D 20 = +35.4 (CHCl3); 1H NMR (400 MHz, CDCl3) δ (ppm) 0.84 (t, J = 7.4 Hz, 3 H), 0.90 (t, J = 7.5 Hz, 3 H), 1.20-1.60 (m, 13 H), 2.00 (m, 2 H), 2.08 (m, 1 H), 2.39 (m, 1 H), 2.65 (m, 1 H), 3.21 (m, 1 H), 3.50 (m, 1 H), 3.75 (m, 1 H), 4.42 (d, J = 11.1 Hz, 1 H), 4.54 (d, J = 11.1 Hz,
1 H), 5.38 (m, 1 H), 5.42 (m, 2 H), 7.30 (m, 5 H). 13C NMR (100 MHz, CDCl3) δ (ppm) 11.0, 12.2, 21.9, 23.4, 24.8, 25.1, 26.9, 29.7, 31.5, 35.3, 39.4, 42.5, 50.3, 72.1, 81.5, 127.4, 127.8 (2 C), 128.3 (2 C), 131.5, 131.7, 139.0, 175.0. MS (EI, 70 eV): m/z 371 (6, M+), 280 (100), 263 (12), 100 (12), 91 (91).

19

Analytical data of 3: Mp 208 °C. [α]D 20 = +50.8 (CHCl3); 1H NMR (400 MHz, CDCl3-CD3OD 1:1) δ (ppm) 0.88 (t, J = 7.5 Hz, 3 H), 0.89 (t, J = 7.1 Hz, 3 H), 1.20-1.75 (m, 22 H), 2.15 (m, 1 H), 2.71 (dt, J = 4.4 and 13.7 Hz, 1 H), 3.48 (m, 1 H), 3.65 (m, 1 H), 5.40 (s, 1 H). 13C NMR (100 MHz, CDCl3/CD3OD 1:1) δ (ppm) 10.9, 12.3, 21.7, 22.1, 26.0 (2 C), 26.3, 26.4, 27.4, 27.6, 32.4, 33.5, 39.6, 44.9, 52.9, 73.7, 178.2. MS (EI, 70 eV): m/z 283 (44, M+), 265 (51), 212 (22), 184 (30), 171 (49), 156 (26), 128 (51), 115 (43), 100 (38), 81 (29), 69 (46), 55 (100), 43 (50).